LSI USA

  Dr. Janani Reisenauer opened the discussion by reflecting on the cultural and technological shifts in healthcare delivery, particularly in the wake of COVID-19. “We’ve seen a rapid resurgence of telemedicine and remote monitoring devices, which are now delivering information directly to patients as consumers rather than routing it through healthcare institutions,” she explained. This shift places patients at the center of care, enabling greater autonomy and access. For more information visit here:  https://issuu.com/lsiusa25/docs/the_evolution_toward_patient-centric_solutions

Technology, private equity, and strategic  medtech partnerships  are reshaping lung cancer care, bringing new innovations to the forefront of early detection and treatment. Lung cancer remains the deadliest cancer worldwide, yet early detection rates continue to lag. While screening and diagnostic advancements hold promise, the complexity of care pathways and industry fragmentation have hindered progress. The panel discussion at LSI USA ’24 —  Lung Cancer at a Tipping Point: Innovation, Private Equity, and Strategic Partnerships Driving Industry Expansion  — brought together leading voices in medtech to discuss how we can drive meaningful change in lung cancer care. The Lung Cancer Care Landscape: A Critical Need for Innovation “Lung cancer is the biggest cancer killer, and unfortunately, it’s an incredibly aggressive disease,” said  David Beylik, Partner at Ajax Health . “The only way to impact care is to catch it early.” Despite the well-documented benefits of...

The future of healthcare innovation is being shaped by a convergence of new technologies, evolving  global medtech market  dynamics, and shifting business models. At LSI USA ’24, two of the industry’s most respected leaders — Alex Gorsky, former Chairman and CEO of Johnson & Johnson, and Rick Anderson, Chairman of Revival Healthcare Capital — shared their perspectives on how  medtech innovation  must evolve to meet the demands of an increasingly complex healthcare landscape. From the rising cost pressures facing healthcare providers to the need for transformational, rather than incremental, technologies,  this discussion  highlighted the fundamental changes required to drive meaningful impact in the industry. “If there was ever a time to be in healthcare — to be thinking about innovation, to be thinking about this nexus of new technologies, and the rigorous clinical regulatory, let alone commercial environment that we work in — now’s the time,” said Ale...